Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Decline Accept
Home › Fund moves › Annovis Bio › Empery Asset Management, LP cut its ANVS stake below 5% (5.0%)
Why it stands out The holder reported owning less than 5%, which ends its duty to keep reporting this stake.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
All the details
Dates, kept separate
Date of the event that required the filing Sep 30, 2026
Reporting period Not applicable
Filed with the SEC Oct 15, 2026 passive 5% holder
Context Change vs prior quarter Undefined
Compared with the manager's prior 13F
Tracked managers with the same change NaN
For the same quarter
0000919574-26-006984
Data quality Verified: identifiers matched exactly
Around the same time Insider filing
Traded Nov 6 · filed the same day
Not classified as an open-market trade.
Insider buying
Largest insider buy since 2020 Traded Nov 6 · filed the same day
An Annovis Bio director paid $5M out of pocket for Annovis Bio shares. It was the first purchase in 6 months. Shares held went up 149% with this purchase.
The story around this disclosure Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
Aug 14, 2026 Company filing · Form 8-K · Results Reported its results What came next Oct 15, 2026 5% stake Empery Asset Management, LP reported a passive stake (13G) of 5.0% Oct 29, 2026 Company filing · Form 8-K · Listing notice, Reg FD Received a notice from its stock exchange, and shared information with investors “On October 29, 2026, Annovis Bio, Inc. (the “Company”) received notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) that it is no longer in compliance with the NYSE continued listing standards set forth in Section 802.01B of the NYSE’s Listed Company Manual due to the fact that the Company’s average market capitalization over a consecutive 30 trading-day period was less than $50 million and, at the…” Nov 3, 2026 Company filing · Form 8-K · Bylaws or charter, Shareholder vote Changed its bylaws, charter or fiscal year, and held a shareholder vote Nov 4, 2026 Company filing · Form 8-K · Results, Reg FD Reported its results, and shared information with investors (and 1 more item) Nov 5, 2026 Company filing · Form 8-K · Material agreement, Reg FD Signed an important agreement, and shared information with investors Nov 6, 2026 Insider · Largest insider buy since 2020 Director purchased ~$5M of ANVS shares in the open market Nov 13, 2026 Company filing · Form 8-K · Results Reported its results 